Catalyst Crew Technologies Corp. (OTC: CCTC) announced that it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval to change its corporate name to LataMed AI Corp. and its trading symbol. The proposed changes, approved by the Company's Board of Directors and majority shareholder, are intended to align the Company's public identity with its transition toward artificial intelligence-enabled healthcare technology, with an initial focus on Latin America.
The Company emphasized that the proposed name and symbol change does not involve any reverse stock split, forward stock split, recapitalization, change to authorized capital, or other modification to its capital structure. The issued and outstanding share count will remain unchanged, and no action will be required by existing shareholders. Upon FINRA approval, the Company plans to file a Certificate of Amendment with the Nevada Secretary of State to effect the name change, which would become effective upon completion of required filings and publication by FINRA on the Daily List.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated, "There is no change to the Company's capital structure as part of this process. This proposed name change is intended to better align the Company's public identity with its healthcare technology strategy and long-term market focus." The Company's strategic direction includes developing scalable digital health solutions for emerging markets, leveraging AI in areas such as telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
Catalyst Crew Technologies, now operating as an AI-driven healthcare technology company, is actively executing its transition and pursuing opportunities through technology development, strategic partnerships, and targeted acquisitions. The Company seeks to address the growing demand for modernized healthcare delivery systems across emerging markets, particularly in Latin America.
No assurance can be given that FINRA will approve the proposed name change or the requested new trading symbol. For more information, visit https://catalystcrewai.com or review the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This press release contains forward-looking statements involving risks and uncertainties. Actual results may differ materially due to factors including the Company's ability to successfully implement its business plan, secure financing, complete acquisitions, comply with regulatory requirements, and general market conditions. The Company undertakes no obligation to update any forward-looking statements except as required by law.
